89 related articles for article (PubMed ID: 6792754)
21. Comparison of in vitro activities of eight new beta-lactam compounds against cephalothin-resistant Enterobacteriaceae from hospital patients.
Costopoulos C; Legakis NJ; Papafragas E; Marinis E
Chemotherapy; 1984; 30(3):158-64. PubMed ID: 6610538
[TBL] [Abstract][Full Text] [Related]
22. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
Bansal MB; Chuah SK; Oryema-Lalobo M; Thadepalli H
Chemotherapy; 1985; 31(3):173-7. PubMed ID: 3996086
[TBL] [Abstract][Full Text] [Related]
23. In-vitro susceptibility of Mycobacterium fortuitum and related strains to cephalosporins.
Haas H; Michel J; Sacks TG
J Med Microbiol; 1973 May; 6(2):141-5. PubMed ID: 4488467
[No Abstract] [Full Text] [Related]
24. Use of beta-lactam/beta-lactamase-inhibitor combinations as antimycobacterial agents.
Prabhakaran K; Harris EB; Randhawa B; Adams LB; Williams DL; Hastings RC
Microbios; 1993; 76(309):251-61. PubMed ID: 8302203
[TBL] [Abstract][Full Text] [Related]
25. 2-aminoimidazoles potentiate ß-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ß-lactamase secretion and increasing cell envelope permeability.
Jeon AB; Obregón-Henao A; Ackart DF; Podell BK; Belardinelli JM; Jackson M; Nguyen TV; Blackledge MS; Melander RJ; Melander C; Johnson BK; Abramovitch RB; Basaraba RJ
PLoS One; 2017; 12(7):e0180925. PubMed ID: 28749949
[TBL] [Abstract][Full Text] [Related]
26. Sch 29482: comparative activity against Enterobacteriaceae multiply-resistant to beta-lactam antibiotics and mycobacteria.
Sanders CC; Sanders WE
J Antimicrob Chemother; 1982 Feb; 9 Suppl C():59-69. PubMed ID: 6977534
[No Abstract] [Full Text] [Related]
27. Penicillin susceptibility testing of gonococci by disc diffusion.
Jacobs MR; Tomashefski JF; Franco A; Anton PA
J Antimicrob Chemother; 1981 Apr; 7(4):319-30. PubMed ID: 6788745
[TBL] [Abstract][Full Text] [Related]
28. [Sensitivity of Pseudomonas aeruginosa to beta-lactam antibiotics and effects of beta-lactamases].
Avril JL; Cayla AM; Guist'hau O; Moillo-Batt A
Pathol Biol (Paris); 1983 Jun; 31(6):471-5. PubMed ID: 6410345
[TBL] [Abstract][Full Text] [Related]
29. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
Tomioka H; Sato K; Saito H
Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
[TBL] [Abstract][Full Text] [Related]
30. Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.
Wang F; Cassidy C; Sacchettini JC
Antimicrob Agents Chemother; 2006 Aug; 50(8):2762-71. PubMed ID: 16870770
[TBL] [Abstract][Full Text] [Related]
31. Mycobacterium terrae: a potential surrogate for Mycobacterium tuberculosis in a standard disinfectant test.
Griffiths PA; Babb JR; Fraise AP
J Hosp Infect; 1998 Mar; 38(3):183-92. PubMed ID: 9561469
[TBL] [Abstract][Full Text] [Related]
32. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.
Woodley CL; Kilburn JO
Am Rev Respir Dis; 1982 Sep; 126(3):586-7. PubMed ID: 6289711
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a bifunctional β-lactamase/ribonuclease and its interaction with a chaperone-like protein in the pathogen Mycobacterium tuberculosis H37Rv.
Sun L; Zhang L; Zhang H; He ZG
Biochemistry (Mosc); 2011 Mar; 76(3):350-8. PubMed ID: 21568871
[TBL] [Abstract][Full Text] [Related]
34. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
Fasola EL; Fasching CE; Peterson LR
J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
[TBL] [Abstract][Full Text] [Related]
35. Determination of in vitro susceptibility of mycobacteria to ansamycin.
Heifets LB; Iseman MD
Am Rev Respir Dis; 1985 Sep; 132(3):710-1. PubMed ID: 3929660
[TBL] [Abstract][Full Text] [Related]
36. Beta-lactamase synthesis in Mycobacterium leprae.
Prabhakaran K; Harris EB; Sanchez RM; Hastings RC
Microbios; 1987; 49(200-201):183-8. PubMed ID: 3295489
[TBL] [Abstract][Full Text] [Related]
37. Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex.
Steadham JE; Stall SK; Simmank JL
Diagn Microbiol Infect Dis; 1985 Jan; 3(1):33-40. PubMed ID: 3917885
[TBL] [Abstract][Full Text] [Related]
38. Isoelectric focusing of beta-lactamases in Mycobacterium fortuitum. Association of a single enzyme pattern with cefoxitin resistance.
Wallace RJ; Nash DR; Udou T; Steingrube VA; Steele LC; Swenson JM; Silcox VA
Am Rev Respir Dis; 1985 Nov; 132(5):1093-7. PubMed ID: 3877482
[TBL] [Abstract][Full Text] [Related]
39. [In vitro antimycobacterial activity of a new quinolone, T-3761].
Tomioka H; Sato K; Saito H
Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
[TBL] [Abstract][Full Text] [Related]
40. Pseudomonas aeruginosa beta-lactamase as a defence against azlocillin, mezlocillin and piperacillin.
Jacobs JY; Livermore DM; Davy KW
J Antimicrob Chemother; 1984 Sep; 14(3):221-9. PubMed ID: 6436226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
